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Abstract
OBJECTIVE: To investigate the antidepressant ef-
fects of the Radix et Caulis Acanthopanacis Santicosi-
extracts in response to the tail suspension test
(TST) and forced swim test (FST) in rats.
METHODS:Male Wistar rats (9-week-old) were oral-
ly administered the Radix et Caulis Acanthopanacis
Santicosi extracts (30, 100 and 300 mg/kg) daily for
14 consecutive days. Serum corticosterone level
was measured by using commercially available kit.
The c-fos immunoreactivity was analyzed using im-
munohistochemistry methods.
RESULTS: The effect of Radix et Caulis Acanthopana-
cis Santicosi extracts on the immobility time was
significantly decreased at high-dose (300 mg/kg)
treated group in the TST and FST (47.7% and 69.6%,
P<0.05), and decreased the hypothalamic-pitu-
itary-adrenal (HPA) axis response to the stress, as in-
dicated by an attenuated corticosterone response
and decreased c-fos immunoreactivity in the hippo-
campal and hypothalamic paraventricular nucleus
region.
CONCLUSION: Radix et Caulis Acanthopanacis Santi-
cosi extracts have beneficial effects on depression
behaviors and restore both altered c-fos expression
and HPA activity. Thus, Radix et Caulis Acanthopana-
cis Santicosi extracts may be a novel agent for the
treatment of stress-related disorders.
© 2014 JTCM. All rights reserved.
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INTRODUCTION
Depression is a common disorder affecting over 120
million people worldwide and recent epidemiological
surveys conducted in general populations have found
that the life time prevalence of depression is in the
range of 10%-15%.1 Despite recent progress in the de-
velopment of clinically relevant antidepressant drugs,
currently available antidepressants are not totally effec-
tive, and are associated with many undesirable adverse
effects.2 Recently, alternative approaches, including the
usage of traditional herbs and dietary interventions,
have been of interest in the management of depres-
sion.3-5
Continued and elevated glucocorticoid levels resulting
from dysfunction of the hypothalamic-pituitary-adre-
nal (HPA) axis is one of the most prominent neurobio-
logical findings in depression.6,7 Glucocorticoid recep-
tors (GR) mediate the direct effects of the glucocorti-
317
JTCM |www. journaltcm. com June 15, 2014 |Volume 34 | Issue 3 |
Gaire B et al. / Experimental Study
coids that are released in response to stress and regulate
the HPA axis via a negative feedback mechanism in the
hippocampus, hypothalamus, and pituitary gland.8,9
Previous clinical studies have reported that depressed
subjects exhibit down-regulation of GR expression,
which subsequently leads to an increase in the endoge-
nous levels of glucocorticoids.10 Thus, GR function
may be one of the potential mechanisms underlying
HPA axis dysfunction.11
Consistent with a role for glucocorticoids in depres-
sions, GR antagonists have been encouraged for poten-
tial therapeutic benefits in stress-related disorders. This
is based on the ability of GR antagonist to block the in-
crease in the levels of circulating glucocorticoids and
on their ability to up-regulate GR.12 Treatment with
the GR antagonist mifepristone; RU486 was recently
reported to ameliorate the symptoms of depression.13-15
Recently, we have investigated the anti-glucocorticoid
activity of the Korean traditional medicine using hor-
mone-responsive element reporter assay,16 and the Ra-
dix et Caulis Acanthopanacis Santicosi extracts signifi-
cantly decreased luciferase activity in response to corti-
sol in a concentration-dependent manner (unpublished
data). Our finding demonstrated that the Radix et Cau-
lis Acanthopanacis Santicosi extracts possesses potent an-
tagonistic activity against glucocorticoid, at least in
part.
Eleutherococcus senticosus, known as Siberian gin-
seng, is a medicinal herb that belongs to the family Ara-
liaceae, and is also known as a powerful tonic herb
with wide range of health benefits. This medicinal herb
has been traditionally used to strengthen muscle and
bone, and tonify Qi.17 Radix et Caulis Acanthopanacis
Santicosi has also been reported to process anti-inflam-
matory,18 anti-tumor,19 anti-depressive,20 anti-steatosis,21
and neuroprotective22 effects. The major active com-
pounds of Radix et Caulis Acanthopanacis Santicosi are
eleutheroside E, chiisanoside, isofraxidin, acanthosides,
daucosterol, sesamin, and they are responsible for its di-
verse biological activities.23 In the present study, the an-
tidepressant effects of Radix et Caulis Acanthopanacis
Santicosi extracts was investigated in response to the
tail suspension test (TST) and forced swim test (FST)
in rats, which may be used as a depression model.24
Moreover, to determine the neurobiological effects un-
derlying the antidepressant activity of the Radix et Cau-
lis Acanthopanacis Santicosi extracts, corticosterone re-
sponses and c-fos immunoreactivity were evaluated in
rats exposed to stress-induced depression.
MATERIALS ANDMETHODS
Preparation of Radix et Caulis Acanthopanacis
Santicosi extracts
Radix et Caulis Acanthopanacis Santicosi was purchased
from Kapdang Co. (Seoul, Korea). The voucher speci-
men (#NP-1033) was deposited in the Functionality
Evaluation Research Group, Korea Food Research Insti-
tute, Seongnam, Korea. Radix et Caulis Acanthopanacis
Santicosi (300 g) was extracted with 70% ethanol
(3000 mL) for 3 h at 80℃ in a reflux apparatus. The
process was repeated once, and the extracts were com-
bined and filtered through a membrane filter (0.45 µm;
Millipore, Billerica, MA, USA). After removing the sol-
vents via rotary evaporation, the remaining extracts
were vacuum dried (yield value-10.5% w/w).
Animals and treatments
8-week-old male Wistar rats (Japan SLC, Inc., Hama-
matsu, Japan) weighing 180-210 g were housed at 2
rats per cage under a controlled temperature (23℃ ±
1℃ ) with a 12 h light/dark cycle (lights on at 07:00
and lights off at 19:00). The rats were allowed at least
1 week for acclimatization before the experiments. All
animal protocols were approved by the Institutional
Animal Care and Use Committee (IACUC) of Korea
Food Research Institute (KFRI-M-12026) containing
ethics committee approval. The rats were divided into
6 groups (n=8 per group) using Latin square design;
normal, control, RU486 (10 mg/kg) and Radix et Cau-
lis Acanthopanacis Santicosi (30, 100 and 300 mg/kg)
group. They were orally administered every day for 14
consecutive days. The vehicle groups; normal
(non-stress) and control were administered the vehicle
solution (distilled water, 1 mL/kg) using the same
schedule of administration. RU486 (Sigma) dissolved
in 50% sesame oil was used as a positive control of anti-
depressant activity.25 On 14th day, the rats were ex-
posed to the behavioral experiments.
TST
The TST was conducted according to modified meth-
ods described Svenningsson et al 26 Briefly, rats were sus-
pended on the edge of a lever 58 cm above a tabletop
using adhesive tape placed approximately 1 cm from
the tip of the tail. The trial was carried out for 6 min
and the duration of immobility was manually recorded
by a blinded observer during the final 5 min interval of
the test. Rats were considered immobile when they
hung passively and motionlessly.
FST
The FST was carried out as previously described.27
Briefly, rats were placed individually in a transparent
Plexiglas cylinder (50 cm × 20 cm) filled with water
(23℃-25℃) till 30 cm depth. Rats were forced to swim
for 15 min, and the immobility time during the last
5 min was manually measured by a blinded observer.
Rats were considered immobile when they ceased strug-
gling, remained floating motionless, and only made
those movements necessary to keep their head above
the water.28
Corticosterone assay and biochemical analysis
The blood was rapidly collected via the abdominal aor-
ta after the onset of the FST. The serum samples were
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prepared by centrifugation of the collected blood sam-
ples (1013 × g for 15 min), then stored at ﹣80℃ for
biochemical determinations. The serum levels of corti-
costerone were measured using commercially available
EIA kits (R&D Systems, Inc., Minneapolis, MN,
USA). The serum concentration of glucose was deter-
mined using an automatic analyzer (ADVIA 1650, Bay-
er, Tokyo, Japan).
Immunohistochemistry
Rats were sacrificed following the FST test, and their
brains were fixed through the ascending aorta with
0.9% saline (Sigma, St. Louis, MO, USA), followed by
500 mL of cold 0.1 M phosphate buffer (PB) (Sigma,
St. Louis, MO, USA) containing 4% paraformalde-
hyde (PFA) (Sigma, St. Louis, MO, USA). The fixed
brains were cut into 30 µm sections on a cryostat
(CM1850; Leica, Heidelberg, Germany). Immunohis-
tochemistry staining was performed on 30 µm sections
using polyclonal antibodies specific for c-fos (1∶500 di-
lution; Santa Cruz Biotechnology, Santa Cruz, CA,
USA), followed by exposure to an Alexa 488-labelled
goat anti-rabbit antibody (1∶500 dilution; Invitrogen,
Paisley, UK). The sections were reacted with an avi-
din-biotin-peroxidase complex kit (Elite ABC kit; 1∶
50 dilution, Vector Laboratories, Burlingame, CA,
USA) at room temperature for 60 min. The avidin-bio-
tin complex was visualized with 0.05% 3, 3-diamino-
benzidine (DAB; Sigma, St. Louis, MO, USA) and
0.02% H2O2.
Statistical analysis
All results were expressed as mean±standard deviation.
Differences between groups were compared using one
way analysis of variance (ANOVA) followed by the
Tukey's Post Hoc test. Dara were processed with
GraphPad Prism 5 (GraphPad Software Inc., La Jolla,
CA, USA). P<0.05 was the significant level.
RESULTS
Depression behaviors in response to the TST and FST
The effects of treatment with Radix et Caulis Acantho-
panacis Santicosi extracts on depression behaviors in re-
sponse to the TST and FST were investigated. The ef-
fect of Radix et Caulis Acanthopanacis Santicosi extracts
on the immobility time was significantly decreased at
high-dose (300 mg/kg) treated group in the TST and
FST (47.7% and 69.6% , P<0.05) (Figure 1A, 1B),
whereas no significant differences in climbing and
swimming behaviors were observed in the FST. RU486
(10 mg/kg) used as the positive control markedly de-
creased the immobility time in the TST and FST
(53.6% and 54.8%, P<0.05).
Serum glucose and corticosterone levels
Glucose and corticosterone levels in the FST-control
group were significantly higher compared to the nor-
mal (non-FST) group. Stress also results in increased
serum glucose concentrations via corticosteroids,
10
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Figure 1 Effects of treatments with Radix et Caulis Acanthopanacis Santicosi extracts on depression behavior in response to the TST
and FST
A: immobility time; B: immobility time; FSTC: swimming; D: climbing. Control group was administered distilled water, 1 mL/kg. Ra-
dix et Caulis Acanthopanacis Santicosi (30, 100, 300 mg/kg) groups were given Radix et Caulis Acanthopanacis Santicosi extracts (30,
100, 300 mg/kg) respectively. RU486 group were given RU486 (10 mg/kg). All groups were orally administered every day for 14
consecutive days. TST: tail suspension test; FST: forced swim test. One hour after the final extract administration, rats was exposed to
theTSTandFSTtest.A-Dwereblindly recordedduringthe last5min intheTSTorFST.TheeffectofRadixetCaulisAcanthopanacis Santi-
cosiextractson the immobility timewas significantlydecreasedat300mg/kg treatedgroup in theTST (A) andFST (B), whereas nodif-
ferences inclimbing(C)andswimmingbehaviors (D)wereobservedintheFST. aP<0.01and bP<0.05,ascomparedwith control group.
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which induce gluconeogenesis in the liver and a reduc-
tion of cellular glucose utilization,29 and induce cate-
cholamine, which promote glucose release by the liv-
er.30 In parallel with serum corticosterone changing, a
transient increase in the serum glucose concentration
was observed under conditions following FST expo-
sure.31 After 14 days of treatments, the Radix et Cau-
lis Acanthopanacis Santicosi extracts 300 mg/kg treat-
ed group showed significantly suppressed glucose and
corticosterone levels compared to the FST-control
group (38.0% and 30.5% , P<0.05) (Figure 2).
RU486 (10 mg/kg) treated group also markedly sup-
pressed glucose and corticosterone levels compared to
the FST control group (48.8% and 22.7%, P<0.05).
c-fos expression in hippocampus and hypothalamic
PVN
To examine whether Radix et Caulis Acanthopanacis
Santicosi extracts affect the neural responses in the rats
exposed to FST, c-fos immunohistochemical density
was measured in the hippocampus and hypothalamic
paraventricular nucleus (PVN). Animals exposed to
FST and treated with vehicle displayed greater c-fos ac-
tivation in the hippocampus and hypothalamic PVN
(Figure 3B, 3H). A significant inhibition of c-fos im-
munoreactivity was observed in the group that was
treated with Radix et Caulis Acanthopanacis Santicosi ex-
tracts at 300 mg/kg (P<0.05) (Figure 3E, 3F).
DISCUSSION
Our results demonstrated that two weeks of treatment
with high-dose Radix et Caulis Acanthopanacis Santicosi
extracts significantly decreased the immobility time in
rats exposed to the TST and FST. Also high-dose Ra-
dix et Caulis Acanthopanacis Santicosi extracts led to de-
creased HPA axis response to the stress since it attenu-
ated corticosterone response and decreased c-fos immu-
noreactivity in the hippocampus and PVN.
Animal models of depression play an important role in
the scientific screening and evaluation of antidepres-
sants. Both TST and FST are widely used for behavior-
al test to screen new antidepressant agents and explore
the underlying mechanism of depression.32-34 After an
initial period of struggling, animals become immobile,
resembling a state of despair and mental disorder. The
state of immobility in the TST and FST reported to
present a condition similar to human depression and
amenable to reversal by antidepressant drugs.35 These
animal models were based on the despair or helpless-
ness behavior to some inescapable and confined space
in animals and are sensitive to various antidepressant
drugs.36 The present results showed that Radix et Caulis
Acanthopanacis Santicosi extracts was effective in pro-
ducing significant antidepressant effects in these mod-
els, especially at the dose of 300 mg/kg. The RU486;
Mifepristone, as a positive control, possesses potent an-
tagonistic activity against glucocorticosteroid action.37
Numerous studies have demonstrated a significant re-
duction in depressive symptoms in patients treated
with RU486.10,13,15 These reports support the notion
that GR antagonists may be useful as antidepressants
for the treatment of depression, via the regulation of
the HPA axis.38 Wulsin et al 39 reported that treatment
with RU486 decreased immobility (but not climbing)
behavior in the FST, consistent with antidepressant ac-
tion via alterations in key limbic circuits mediating cen-
tral nervous system stress responses. Consistent with
our findings in the RU486 treated group, high-dose
Radix et Caulis Acanthopanacis Santicosi extracts might
have antidepressant activity in rats exposed to the
stress-induced depression behavior.
The antidepressant activity of high-dose Radix et Cau-
lis Acanthopanacis Santicosi extracts was confirmed via
the quantitative analyses of c-fos immunoreactivity and
of the activity of the HPA axis, which are associated
with high corticosterone production. Previous studies
involving acute or chronic stress states have demon-
strated that profound alterations in GR mRNA expres-
sion are closely associated with elevated corticosterone
production and c-fos expression.40 Antidepressant drug,
including selective serotonin reuptake inhibitors, com-
pensate impaired feedback inhibition by regulating GR
levels in hippocampal regions.41 Therefore, it seems
a
b
c
30 100 300ControlNormal
a
b
b
30 100 300ControlNormal
A B
Figure 2 Effect of Radix et Caulis Acanthopanacis Santicosi extracts on serum corticosterone and glucose levels
A: corticosterone; B: glucose. Control group was administered distilled water, 1 mL/kg. Radix et Caulis Acanthopanacis Santicosi
(30, 100, 300 mg/kg) groups were given Radix et Caulis Acanthopanacis Santicosi extracts (30, 100, 300 mg/kg) respectively. RU486
group were given RU486 (10 mg/kg). All groups were orally administered every day for 14 consecutive days. After 14 days of treat-
ments, the Radix et Caulis Acanthopanacis Santicosi extracts 300 mg/kg treated group showed significantly suppressed corticoste-
rone (A) and glucose (B) levels compared to the FST-control group. aP<0.01, as compared with normal group and bP<0.05, cP<0.01,
as compared with control group.
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that decreasing neural activity in the hippocampal re-
gions normalizes via altered HPA activity. Consistent
with this idea, we found that treatment with high-dose
Radix et Caulis Acanthopanacis Santicosi extracts allevi-
ated not only the increase in c-fos-positive cells in the
hippocampus and hypothalamic PVN associated with
stress-induced depression, but also the HPA axis re-
sponse to stress. Although we did not determine GR
phosphorylation and GR-dependent transactivation in
hippocampus and hypothalamic PVN, our findings
a
cb
30 100 300ControlNormal
2
cb
a
30 100 300ControlNormal
E F
CBA
D
G H I
J K L
Figure 3 Effects of high-dose Radix et Caulis Acanthopanacis Santicosi extracts on c-fos expression in hippocampus region and hy-
pothalamic PVN
A-F: c-fos immunostained nucleus in hippocampus; G-L: c-fos expression in hypothalamic PVN; A, G: Control group was adminis-
tered distilled water, 1 mL/kg; B, H: RU486 group were given RU486 (10 mg/kg); C, I: Radix et Caulis Acanthopanacis Santicosi ex-
tracts 30 mg/kg; D, J: Radix et Caulis Acanthopanacis Santicosi 30 mg/kg; E, K: Radix et Caulis Acanthopanacis Santicosi extracts
100 mg/kg; F, L: Caulis Acanthopanacis Santicosi extracts 300 mg/kg. All groups were orally administered every day for 14 consecu-
tive days. PVN: paraventricular nucleus. Mean±SD values of c-fos immunostained nucleus in hippocampus (M) and hypothalamic
PVN (N). aP<0.001, as compared with the normal group, bP<0.01 and cP<0.05, as compared with the control group.
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suggest that high-dose Radix et Caulis Acanthopanacis
Santicosi extracts reverse the downregulation of hippo-
campal GR expression in rats exposed to antidepres-
sant effects of Radix et Caulis Acanthopanacis Santicosi
extracts stress, indicating a direct relationship between
the antidepressant effects of Radix ex Caulis Acantho-
panacis Santicosi extracts and GR signaling.
In summary, treatment with high-dose Radix et Caulis
Acanthopanacis Santicosi extracts significantly decreased
the immobility time in rats exposed to the TST and
FST, and decreased the HPA axis response to the stress,
as indicated by an attenuated corticosterone response
and decreased c-fos immunoreactivity in the hippocam-
pal hypothalamic PVN region. These findings demon-
strated that Radix et Caulis Acanthopanacis Santicosi ex-
tracts can restore both altered c-fos expression and
HPA activity and have beneficial effects on depressive
behaviors.
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